Professor Ruth Roberts Joins Chair Dr Myrtle Davis at the Drug Safety Gordon Research Conference

Drug Safety Gordon Research Conference

Professor Ruth Roberts, Director and Co-founder of ApconiX will be joining Dr Myrtle Davis, Scientific Vice President, Discovery Toxicology, Bristol Myers Squibb as Vice Chair of the at the Gordon Research Conference (GRC) at Stonehill College Easton, MA, United States.  Myrtle will Chair the Drug Safety GRC “Advances in Models, New Modalities and Clinical Considerations for Drug Safety” between 19th and 24th June 2022

Drug Safety Gordon Research Conference: 

Drug safety describes the potential for adverse effects that are related to the administration of drugs. Key challenges in drug discovery and development are identifying and solving potential safety problems as early as possible in the nonclinical or clinical setting. Advancements in the approaches used to characterize toxicities have resulted in identification of safety biomarkers and clear opportunities to aid in understanding mechanisms of clinically-important adverse drug reactions. The unique goal of the science applied to drug safety is to improve the benefit-risk ratio of investigational drugs and ultimately, improve the safety profiles and tolerability of therapies. The session themes will highlight various concepts and approaches that are addressing the key challenges in drug safety. A unique attribute of the Drug Safety GRC is the specific intent to create science-based partnerships among drug safety scientists and experts from many disciplines.


  • Keynote: Modelling Complex Biological Systems
  • Big Data and Machine Learning in Safety Assessment
  • Leveraging Human Genetics and Big Data to Inform Drug Safety
  • Biomarker Science in Drug Discovery and Development
  • Microphysiological Models: Advances in Modelling Complex In Vivo Functions and Organ Responses
  • New Paradigms in Translational Safety Science
  • Novel Therapeutic Modalities: Challenges and Opportunities in Nonclinical Safety Assessment Strategies
  • Keynote: Advancing Drug Safety Through Innovation

Contact for more information:

  • Chair: Myrtle Davis, Bristol-Myers Squibb (
  • Vice Chair: Ruth Roberts, ApconiX (

Click here for more details of the drug safety GRC programme

Applications for this meeting must be submitted by May 22, 2022. Click here to apply

This GRC will be held in conjunction with the “Drug Safety (GRS)” Gordon Research Seminar (GRS).

Drug Safety Gordon Research Seminar: 

The Gordon Research Seminar on Drug Safety “Emerging Technologies and Strategies for Drug Safety Evaluation” will be held on the 18th and 19th June 2022 and brings together graduate students, post-doctoral scholars, and early career scientists in a multidisciplinary setting that overviews new advances in fields such as toxicology, precision medicine, computational biology, bioengineering, immunology, and gene editing. The Seminar will focus on novel technologies and strategies to improve drug safety evaluation. Attendees are expected to share their unpublished research in the form of a poster, and exceptional abstracts will be selected for platform presentations. In addition to extensive presentation and networking opportunities, attendees will have access to mentorship and career advice from established industry, academic, and government investigators.

The seminar will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS, either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.

The seminar chair will select speakers from abstracts submitted by March 18, 2022. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster.

Gordon Research Seminars are 2-day meetings which take place on the Saturday and Sunday just prior to the start of the associated GRC. The GRS opens with a 1-hour introductory session on Saturday afternoon, followed by a poster session, dinner and a 2-hour session in the evening. Sunday morning begins with breakfast and is followed by another 2-hour session, a second poster session, and lunch. A final 1-hour session takes place just after lunch, and the associated GRC begins later that evening.


  • Focused on graduate & postdoctoral trainees
  • Career development session: First steps to a job in academia, industry or government

Spaces available for over 10 graduate student and postdoctoral fellow speakers

  • Submit abstracts by March 18, 2022 to be considered for an oral presentation

Contact for more information:

  • Chair: Lauren Lewis, Bristol-Myers Squibb
  • Chair: Molly Morgan, Crown Biosciences

For more information visit the GRS website